Back to top
more

Franklin Genomic Advancements ETF: (HELX)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Apr 19, 2024 02:33 PM ET

$29.32 USD

29.3241
782

-0.33 (-1.11%)

Volume: 782

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $29.43 +0.11 (0.36 %) 7:22 PM ET

ETF Quote Details

Previous Close 29.65
Open 29.36
Bid 28.99
Ask 29.81
Day Low-High 29.32-29.36
52wk Low-High 25.26-32.92
Volume 782
NAV (month end) 32.76
Premium (+)/Discount (-) (month end)-3.11

Zacks Premium Research for HELX

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA

ETF Expense Ratio

Expense Ratio 0.50%
Dividend (Yield) $0.00 (0.00%)
Issuer FRANKLIN TEMPLETON INVESTMENTS

Benchmark for HELX

----------------------------------------

This ETF is active and does not track a benchmark.

Fund Summary for HELX

FRANKLIN GENOMIC ADVANCEMENTS ETF

The Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.